MIME-Version: 1.0
Content-Location: file:///C:/099CDED5/34cda489575a4bdd863e42c279c88655.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="utf-8"

<html xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8">
<meta name=3DProgId content=3DOneNote.File>
<meta name=3DGenerator content=3D"Microsoft OneNote 15">
<link id=3DMain-File rel=3DMain-File href=3D34cda489575a4bdd863e42c279c8865=
5.htm>
<link rel=3DFile-List href=3D"34cda489575a4bdd863e42c279c88655.files/fileli=
st.xml">
</head>

<body lang=3Dzh-TW style=3D'font-family:Calibri;font-size:11.0pt'>

<div style=3D'direction:ltr;border-width:100%'>

<div style=3D'direction:ltr;margin-top:0in;margin-left:0in;width:6.5923in'>

<div style=3D'direction:ltr;margin-top:0in;margin-left:.3368in;width:5.8013=
in'>

<p style=3D'margin:0in;font-family:"Microsoft JhengHei Light";font-size:20.=
0pt'
lang=3Den-GB>深層靜脈栓塞（Deep vein thrombosis, DVT）</p>

</div>

<div style=3D'direction:ltr;margin-top:.0388in;margin-left:.3368in;width:1.=
5444in'>

<p style=3D'margin:0in;font-family:Calibri;font-size:10.0pt;color:#666666'
lang=3Den-GB>07 April 2025</p>

<p style=3D'margin:0in;font-family:Calibri;font-size:10.0pt;color:#666666'
lang=3Den-GB>12:00</p>

</div>

<div style=3D'direction:ltr;margin-top:.3965in;margin-left:0in;width:6.5923=
in'>

<ul style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:=
0in'>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#24=
4061'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16.=
0pt'>定義</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>DVT</span><span style=3D'font-family:微軟正=
體;font-size:
       11.0pt;color:black'>：一種或多種血栓於深層靜脈形成，=
</span><span style=3D'font-family:
       微軟正黑體;font-size:11.0pt;color:#C00000'>最常在下肢發=
</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0=
pt'>靜脈血栓栓塞症（Venous
       Thromboembolism, VTE）</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:#F79646'>包含 DVT 與 肺栓塞（Pulmonary Embolism=
, PE）</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
（PE於另一章節討論）</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>復發性 VTE（Recurrent VTE）</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>：</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>接受抗凝血治療兩週後再次發生
         VTE</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>誘發型 VTE（Provoked VTE）</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>：有</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>多於一個VTE危險因子</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>的病人 </span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>非誘發型/特發性 VTE（Unprovoked/Idiopa=
thic VTE）</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>：</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>無明確風險因子</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>下發生VTE</span></li>
    </ul>
   </ul>
  </ul>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#24=
4061'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16.=
0pt'>流行病學</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C=
00000'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>VTE 發生率</span><span style=3D'font-family:=
軟正黑體;
       font-size:11.0pt;color:black'>：約</span><span style=3D'font-famil=
y:微軟正黑體;
       font-size:11.0pt;color:#C00000'>每年每10萬人中有100人</span>=
</li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>其中</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'> 20%
        是在術後三個月內出現</span></li>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>肺栓塞（PE）</span><span style=3D'font-fam=
ily:微軟正黑體;
        font-size:11.0pt;color:black'>：佔 VTE </span><span style=3D'font=
-family:
        微軟正黑體;font-size:11.0pt;color:#C00000'>1/3</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>深層靜脈栓塞（DVT）</span><span style=
=3D'font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：佔 </span><span style=3D'font-fam=
ily:微軟正黑體;
        font-size:11.0pt;color:#C00000'>2/3</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C=
00000'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>臺灣的 VTE 每年發生率</span><span style=
=3D'font-family:微軟正黑體;
       font-size:11.0pt;color:black'>：</span><span style=3D'font-family:=
軟正黑體;
       font-size:11.0pt;color:#C00000'>每10萬人中有 16–17 例</span>=
</li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C=
00000'
       lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:11=
.0pt;color:#C00000'>發生率隨年齡增加而上升</span><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
80 歲時的發生率為每年
       0.5%（美國）</span></li>
  </ul>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#24=
4061'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16.=
0pt'>分類</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#3=
66092'
       lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:14=
.0pt'>根據位置：上肢/下肢、近端/遠端</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>下肢</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>近端（Proximal DVT）</span><span style=3D'=
font-family:
         微軟正黑體;font-size:11.0pt;color:black'>：影響</span><spa=
n style=3D'font-weight:
         bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>=
靜脈（femoral
         vein）、深股靜脈（profunda femoris vein）、膕靜脈（po=
pliteal vein）</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>，範圍至</span><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt;color:#F79646'>小腿靜脈分叉處（calf
         vein trifurcation）</span><span style=3D'font-family:微軟正黑=
體;font-size:
         11.0pt;color:black'>為止</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>遠端（Distal DVT）</span><span style=3D'fo=
nt-family:
         微軟正黑體;font-size:11.0pt;color:black'>：小腿靜脈分=
處以下（</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>膝關節以下</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>）的靜脈</span></li>
    </ul>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>上肢（Upper
        extremity deep vein thrombosis, UEDVT）</span><span style=3D'font-=
family:
        微軟正黑體;font-size:11.0pt'>（另於UEDVT章節討論，本=
著重討論下肢 DVT ）</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>近端 UEDVT</span><span style=3D'font-family:=
微軟正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-family=
:微軟正黑體;
         font-size:11.0pt;color:#C00000'>腋靜脈（axillary vein）、鎖=
骨下靜脈（subclavian
         vein）</span></li>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>遠端 UEDVT</span><span style=3D'font-family:=
微軟正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-weight=
:bold;
         font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>肱靜=
脈（brachial
         vein）、橈靜脈（radial vein）、尺靜脈（ulnar vein）=
骨間靜脈（interosseous veins）</span></li>
    </ul>
   </ul>
  </ul>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#24=
4061'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16.=
0pt'>病因</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:#C00000'>Virchow triad</span><span style=3D'font-family=
:微軟正黑體;
       font-size:11.0pt;color:black'>（見病生理）</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0=
pt'>危險因子</span></li>
  </ul>
 </ul>
 <div style=3D'direction:ltr'>
 <table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'di=
rection:ltr;
  border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-w=
idth:
  1pt;margin-left:.3333in' title=3D"" summary=3D"">
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:2.975in;padding:2.0pt =
3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:微軟正黑體;font-size:11.0pt' lan=
g=3Den-US>暫時性（Transient
   risk factors）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:2.7333in;padding:2.0pt=
 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:微軟正黑體;font-size:11.0pt' lan=
g=3Den-US>慢性（Chronic
   risk factors）</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.975in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin-top:5pt;margin-bottom:5pt;font-family:微軟正黑體=
;font-size:11.0pt'
   lang=3Den-US><span style=3D'font-weight:bold'>手術：</span><span styl=
e=3D'color:#C00000'>全身麻醉、剖腹產</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.8027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:微軟正黑體;font-size:11.0pt' lan=
g=3Den-US><span
   style=3D'font-weight:bold'>病人因素</span></p>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>年齡 &gt; 60
        歲</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>有 DVT 或 PE
        病史或家族史</span></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>解剖異常</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>導致靜脈=
鬱積</span></li>
    <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt'>骨盆腫瘤壓迫髂靜脈</span></li>
    </ul>
    <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:#F79646'>May-Thurner syndrome</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>：在右髂動脈跨過左髂靜脈的位置，左側髂靜脈受到壓=
，導致髂股靜脈血栓形成</span></li>
    </ul>
   </ul>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.975in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:微軟正黑體;font-size:11.0pt' lan=
g=3Den-US><span
   style=3D'font-weight:bold'>活動受限（Immobilization）</span></p>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>因急性疾病需</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt;color:#C00000'>長時間臥床</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt' lang=3Den-US>下肢受傷導致活動受限
        </span><span style=3D'font-weight:bold;font-family:"Microsoft Jheng=
Hei Light";
        font-size:11.0pt' lang=3D"x-IV_mathan">≥</span><span style=3D'fon=
t-weight:
        bold;font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US> 3 =
天</span></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:#C00000'>長途旅行（&gt;6小時）</span></li>
   </ul>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.8027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:微軟正黑體;font-size:11.0pt' lan=
g=3Den-US><span
   style=3D'font-weight:bold'>慢性疾病</span></p>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>活動性癌症</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>腎病症候群</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>自體免疫疾病</span><span style=3D'font-fa=
mily:微軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style=3D'font-family:=
微軟正黑體;
        font-size:11.0pt;color:#C00000'>抗磷脂抗體症候群（APLA）=
發炎性腸道疾病</span></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:#C00000'>骨髓增生性疾病</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
（myeloproliferative
        disorders）</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:#C00000'>紅血球增多症</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
（polycythemia）</span></li>
   </ul>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.975in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:微軟正黑體;font-size:11.0pt' lan=
g=3Den-US><span
   style=3D'font-weight:bold'>雌激素相關</span></p>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>懷孕</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>使用口服避孕藥</span></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>荷爾蒙補充療法</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>（Hormone r=
eplacement
        therapy, HRT）</span></li>
   </ul>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.8027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:微軟正黑體;font-size:11.0pt' lan=
g=3Den-US><span
   style=3D'font-weight:bold'>遺傳性高凝狀態（Hereditary thrombophi=
lia）</span></p>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:#C00000'>第五因子
        Leiden 突變</span><span style=3D'font-family:微軟正黑體;font=
-size:11.0pt;
        color:black'>（Factor V Leiden mutation）</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:#C00000'>抗凝血酶
        III （Antithrombin III）缺乏</span></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>Protein C、S
        缺乏</span></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:#C00000'>凝血酶原基因（20210A）突變（Prothrombin
        mutation） </span></li>
   </ul>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.975in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:微軟正黑體;font-size:11.0pt' lan=
g=3Den-US><span
   style=3D'font-weight:bold'>血管內裝置（Intravascular devices） </=
span></p>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>留置靜脈導管</span><span style=3D'font-fa=
mily:微軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style=3D'font-weight:=
bold;
        font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>CVC 與=
兒童VTE發生率有關</span></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:#F79646'>植入式心律調節器（pacemaker）或去=
顫器（defibrillator）</span></li>
   </ul>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.7333in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:微軟正黑體;font-size:11.0pt' lan=
g=3Den-US><span
   style=3D'font-weight:bold'>同時具有遺傳與後天因素</span></p>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>高半胱胺酸血症（Homocysteinemia）</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>factors
        VII, VIII, IX, and XI 上升</span></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:#C00000'>高纖維蛋白原血症</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
（Hyperfibrinogenemia）</span></li>
   </ul>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.975in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:微軟正黑體;font-size:11.0pt' lan=
g=3Den-US><span
   style=3D'font-weight:bold'>病人因素</span></p>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>肥胖</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>抽菸</span></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt'>靜脈注射毒品</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt'>對 VTE 預防治療的依從性低</span></li>
   </ul>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.7333in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:微軟正黑體;font-size:11.0pt;colo=
r:#C00000'
   lang=3Den-US>&nbsp;</p>
   </td>
  </tr>
 </table>
 </div>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#24=
4061'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16.=
0pt'>病生理</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:14=
.0pt;color:#366092'>Virchow
       triad</span><span style=3D'font-family:微軟正黑體;font-size:11.=
0pt;color:black'>（口訣：「HE’S
       Virchow」）</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>德國病理=
學家Rudolf
        Virchow提出，靜脈血栓形成的三大主要病生理機制</s=
pan></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>高凝血狀態（Hypercoagulability）</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt;color:black'>大手術後會使</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>大量組織因子（tissue
         factor）從受損組織釋放至血液中</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt'>組織因子是強力的促凝血物質，會表現在白血球細=
胞表面，亦可以可溶型態出現在血液中</span></li>
     </ul>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt;color:black'>生理性壓力（大手術或創傷）會引起</span>=
<span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>血小板數量與黏附性增加</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>、</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>凝血階梯瀑布 效應</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>（Coagulation
         cascade）以及</span><span style=3D'font-family:微軟正黑體;=
font-size:11.0pt;
         color:#C00000'>內生性纖維蛋白溶解活化物</span><span st=
yle=3D'font-family:微軟正黑體;
         font-size:11.0pt;color:black'>（endogenous fibrinolytic activity=
</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>的變化</span></li>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>凝血傾向改變</span><span style=3D'font-f=
amily:微軟正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-family=
:微軟正黑體;
         font-size:11.0pt;color:#C00000'>Factor V Leiden突變</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>使用口服避孕藥、懷孕</span></li>
    </ul>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>血管內皮損傷（Endothelial
        damage）</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt;color:black'>發炎或外傷導致</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>血管損傷</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>，</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>暴露出來的血管內皮下方的膠原纖維（subendothelial
         collagen）會啟動凝血因子</span></li>
    </ul>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>靜脈血液滯留（Venous
        stasis）</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt'>原因</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:#C00000'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt'>靜脈曲張</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:#C00000'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt'>肢體外部壓迫</span></li>
     </ul>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:#F79646'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt;
          color:#C00000'>Immobilization</span><span style=3D'font-family:=
軟正黑體;
          font-size:11.0pt;color:black'>：</span><span style=3D'font-weigh=
t:bold;
          font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>住=
、長期臥床、長途飛機或公車</span></li>
     </ul>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:#C00000'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt'>局部熱敷</span></li>
     </ul>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:#F79646'>腓腸肌靜脈竇（soleal sinuses）</span=
><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>是靜脈血栓形成最常見的起始部位</span></li>
    </ul>
   </ul>
  </ul>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#F=
79646'
       lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:11=
.0pt;color:black'>因以上原因形成的血栓</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0=
pt;color:#F79646'>可能由起始靜脈延伸至近端深層靜脈系統，=
導致水腫、疼痛與活動困難</span></li>
  </ul>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#24=
4061'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16.=
0pt'>臨床表現</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0=
pt'>可能無症狀</span></li>
  </ul>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#F=
79646'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>局部單側症狀（Localized unilateral）</sp=
an></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>病變區域</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>腫脹（swelling），有緊繃感或沉重感</span></li>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:#C00000'>皮膚熱、出現紅斑</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
，</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt;color:#F79646'>可能出現青紫變色</span></li>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>漸進性的壓痛、隱隱作痛（dull
        pain）</span></li>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>Signs</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:#C00000'>Homans sign</span><span style=3D'font-family=
:微軟正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-weight=
:bold;
         font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>足部=
背屈時引起小腿疼痛</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:#C00000'>Meyer sign</span><span style=3D'font-family:=
微軟正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-weight=
:bold;
         font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>壓迫=
小腿</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>時產生疼痛</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:#C00000'>Payr sign</span><span style=3D'font-family:=
軟正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-weight=
:bold;
         font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>按壓=
足底內側</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>時出現疼痛</span></li>
    </ul>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>淺層靜脈擴張</span></li>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt'>遠端動脈脈搏通常正常</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#F=
79646'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>全身性症狀</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>發燒</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>肺栓塞症狀</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>呼吸困難、胸痛、頭暈、虛弱</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#F=
79646'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>青腫性靜脈炎（phlegmasia cerulea dolens=
</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>血栓廣泛</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>影響到下肢主要深靜脈通道</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
（major axial
        deep venous channels），但側枝靜脈相對未受影響</span><=
/li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>特徵</span><span style=3D'font-family:微軟=
黑體;font-size:
        11.0pt;color:black'>：</span><span style=3D'font-family:微軟正=
體;font-size:
        11.0pt;color:#C00000'>疼痛、凹痕性水腫（pitting edema）=
發紺（cyanosis）</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#F=
79646'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>白腫性靜脈炎（phlegmasia alba dolens）</=
span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>血栓</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>進一步延伸至側枝靜脈</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
，導致</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>大量體液滯留與更嚴重的水腫</span></li>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>患肢會因為</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt;color:#F79646'>小腿以下筋膜室壓力顯著升高</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
，導致</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>動脈灌流不足</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
，出現</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>極度疼痛、嚴重水腫與蒼白</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#F=
79646'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>靜脈性壞疽（venous gangrene）</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>青腫性或白腫性靜脈炎惡化時的併發症，</=
span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>嚴重時可能需要截肢</span></li>
   </ul>
  </ul>
 </ul>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16.=
0pt;color:#244061'>診斷</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16=
.0pt;color:#244061'>流程</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>先用
        </span><span style=3D'font-family:微軟正黑體;font-size:11.0pt;=
color:#C00000'>Wells
        score</span><span style=3D'font-family:微軟正黑體;font-size:11=
.0pt;color:black'>
        計算 DVT 機率</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:#F79646'>低風險（0分）</span><span style=3D'fon=
t-family:微軟正黑體;
         font-size:11.0pt;color:black'>→ </span><span style=3D'font-famil=
y:微軟正黑體;
         font-size:11.0pt;color:#C00000'>D-dimer</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt;color:black'>D-dimer</span><span style=3D'font-f=
amily:
          微軟正黑體;font-size:11.0pt;color:black'>：</span><span sty=
le=3D'font-weight:
          bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>=
陰性（&lt;500
          ng/mL）</span><span style=3D'font-family:微軟正黑體;font-si=
ze:11.0pt;
          color:black'>：</span><span style=3D'font-family:微軟正黑體=
;font-size:11.0pt;
          color:#C00000'>排除 DVT</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'><span
          style=3D'font-weight:bold;font-family:微軟正黑體;font-size:1=
1.0pt;
          color:black' lang=3Den-US>D-dimer</span><span style=3D'font-famil=
y:微軟正黑體;
          font-size:11.0pt;color:black' lang=3Den-US>：</span><span
          style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C000=
00' lang=3Den-US>陽性（</span><span
          style=3D'font-family:"Microsoft JhengHei Light";font-size:11.0pt;
          color:#C00000' lang=3D"x-IV_mathan">≥</span><span style=3D'font=
-family:
          微軟正黑體;font-size:11.0pt;color:#C00000' lang=3Den-US>500 =
ng/mL）</span><span
          style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black=
' lang=3Den-US>：懷疑
          DVT → </span><span style=3D'font-family:微軟正黑體;font-si=
ze:11.0pt;
          color:#C00000' lang=3Den-US>靜脈超音波</span></li>
     </ul>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:#C00000'>中或高風險（</span><span style=3D'font=
-weight:bold;
         font-family:"Microsoft JhengHei Light";font-size:11.0pt;color:#C00=
000'>≥</span><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt;color:#C00000'>
         1分）</span><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt;color:black'>，或
         </span><span style=3D'font-weight:bold;font-family:微軟正黑體=
;font-size:11.0pt;
         color:#C00000'>低風險但 D-dimer 陽性</span><span style=3D'fo=
nt-family:微軟正黑體;
         font-size:11.0pt;color:black'> → </span><span style=3D'font-fami=
ly:微軟正黑體;
         font-size:11.0pt;color:#C00000'>靜脈超音波</span></li>
    </ul>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16=
.0pt;color:#244061'>Wells
       score</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>臨床上預=
測DVT的計算工具</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt'>評估肺=
塞（PE）的也叫 Wells
         score，但評分項目與標準跟 DVT 有差異</span></li>
    </ul>
   </ul>
  </ul>
 </ul>
 <div style=3D'direction:ltr'>
 <table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'di=
rection:ltr;
  border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-w=
idth:
  1pt;margin-left:.3333in' title=3D"" summary=3D"">
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:2.1729in;padding:2.0pt=
 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>分類</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:3.0638in;padding:2.0pt=
 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>評分項目 </span>=
</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:.5583in;padding:2.0pt =
3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>分數</span></p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>病史</span><br>
      <span style=3D'font-weight:bold'>（Medical history）</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:3.0638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:#C00000'>活動性癌症</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;text-align:c=
enter'>&nbsp;</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:3.0638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:#C00000'>有 DVT 病史</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>不動狀態</span><=
br>
      <span style=3D'font-weight:bold'>（Immobilization）</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:3.0638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'><span
   style=3D'color:#C00000'>下肢麻痺、輕癱</span>，或近期因骨=
需使用<span style=3D'color:#C00000'>石膏固定</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;text-align:c=
enter'>&nbsp;</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:3.0638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>最近<span
   style=3D'color:#C00000'>臥床超過 3 天</span>，或<br>
      在<span style=3D'color:#C00000'>過去 12 週內接受過大手術</=
span>（全身或局部麻醉）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>臨床表現</span><=
br>
      <span style=3D'font-weight:bold'>（Clinical features）</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:3.0638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>深層靜脈系統處<span
   style=3D'color:#C00000'>有局部壓痛</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;text-align:c=
enter'>&nbsp;</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:3.0638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>整條腿<span
   style=3D'color:#C00000'>腫脹</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;text-align:c=
enter'>&nbsp;</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:3.0638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:#C00000'>患側小腿腫脹程度大於健側 ≥ 3cm</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;text-align:c=
enter'>&nbsp;</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:3.0638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'>患側的小腿<span
   style=3D'color:#C00000'>凹痕性水腫（pitting edema）</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;text-align:c=
enter'>&nbsp;</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:3.0638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt=
'><span
   style=3D'color:#C00000'>側枝表淺靜脈擴張</span>（<span style=3D=
'font-weight:bold;
   color:#F79646'>非靜脈曲張 nonvaricose</span>）</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>+1</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:2.1729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>鑑別診斷</span><=
br>
      <span style=3D'font-weight:bold'>（Differential diagnosis）</span><=
/p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:3.0638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:#F79646'><span style=3D'font-weight:bold'>有其他更可能的診=
斷能解釋症狀</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;color:#C0000=
0'>-2</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:2.1729in;padding:2.0pt=
 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style=3D'font-weight:bold'>綜合評分</span><=
/p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:3.0638in;padding:2.0pt=
 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;text-align:c=
enter'>DVT
   風險</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:.5in;padding:2.0pt 3.0=
pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#EBF1DD;vertical-align:top;width:2.1729in;padding:2.0pt=
 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;text-align:c=
enter'><span
   style=3D'font-weight:bold'>0分</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#EBF1DD;vertical-align:top;width:3.0638in;padding:2.0pt=
 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'>低</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#FDEADA;vertical-align:top;width:2.1729in;padding:2.0pt=
 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;text-align:c=
enter'><span
   style=3D'font-weight:bold'>1-2分</span></p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#FDEADA;vertical-align:top;width:3.0638in;padding:2.0pt=
 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'>中</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
   </td>
  </tr>
  <tr>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2DCDB;vertical-align:top;width:2.1729in;padding:2.0pt=
 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei Light";font-size:=
11.0pt;
   text-align:center' lang=3Den-US>≥ 3分</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2DCDB;vertical-align:top;width:3.0638in;padding:2.0pt=
 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'>高</p>
   </td>
   <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
   vertical-align:top;width:.5in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
   </td>
  </tr>
 </table>
 </div>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#36=
6092'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:14.=
0pt'>D-dimer</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C=
00000'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>適應症</span><span style=3D'font-family:微=
正黑體;font-size:
       11.0pt;color:black'>：</span><span style=3D'font-family:微軟正=
體;font-size:
       11.0pt;color:#C00000'>沒有懷孕、Wells score低風險（0分）<=
/span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C=
00000'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>正常範圍</span><span style=3D'font-family:=
軟正黑體;
       font-size:11.0pt;color:black'>：</span><span style=3D'font-family:=
軟正黑體;
       font-size:11.0pt;color:#C00000'>&lt;500 ng/mL</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C=
00000'
       lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:11=
.0pt'>敏感度高（96%），但特異性低（36%）</span></li>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>適用於低風險，用以排除
        DVT</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>中高風險不能用作排除
        DVT</span></li>
   </ul>
  </ul>
 </ul>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#36=
6092'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:14.=
0pt'>下肢靜脈超音波（Lower
      extremity venous ultrasound）</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0=
pt'>適應症</span></li>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US=
>Wells score 中高風險（</span><span
        style=3D'font-family:"Microsoft JhengHei Light";font-size:11.0pt'
        lang=3D"x-IV_mathan">≥</span><span style=3D'font-family:微軟正=
黑體;font-size:
        11.0pt' lang=3Den-US> 1）</span></li>
   </ul>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:#C00000'>懷孕或術後病人</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
（</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt;color:#F79646'>即使低風險，也應優先做
        US</span><span style=3D'font-family:微軟正黑體;font-size:11.0p=
t;color:black'>）</span></li>
   </ul>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>低風險 但
        D-dimer 陽性</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0=
pt'>支持性發現</span></li>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>靜脈無法壓扁</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>靜脈腔內有高回音質塊（Intraluminal
        hyperechoic mass）</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>靜脈擴張</span></li>
   </ul>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>Doppler 發現</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt;color:#C00000'>靜脈無血流（complete）或血流異常（partia=
l）</span></li>
    </ul>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>擠壓小腿或
         Valsalva maneuver 時血流沒有增強</span></li>
    </ul>
   </ul>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>若為</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt;color:black'>復發性
        DVT（recurrent DVT）</span><span style=3D'font-family:微軟正=
體;font-size:11.0pt;
        color:black'>：</span><span style=3D'font-weight:bold;font-family:=
微軟正黑體;
        font-size:11.0pt;color:#F79646'>發現新形成的血栓或原阻=
靜脈的壓縮度增加 &gt;4 mm</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0=
pt'>結果判讀</span></li>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>陰性</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>低或中風險（Wells score 0-2分）</span>=
<span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>：</span><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt;color:#F79646'>可排除
         DVT</span></li>
    </ul>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>高風險（Wells score </span><span style=3D'=
font-weight:
         bold;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
         color:black'>≥</span><span style=3D'font-weight:bold;font-family=
:微軟正黑體;
         font-size:11.0pt;color:black'> 3分）</span><span style=3D'font-f=
amily:
         微軟正黑體;font-size:11.0pt;color:black'>：若無其他診=
，</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>1 週內再做一次 US</span></li>
    </ul>
   </ul>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>陽性</span><span style=3D'font-family:微軟=
黑體;font-size:
        11.0pt;color:black'>：</span><span style=3D'font-family:微軟正=
體;font-size:
        11.0pt;color:#C00000'>確診 DVT</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt'>若病人=
明確的危險因子，需找出引起 DVT 的潛在病因</span></li>
    </ul>
   </ul>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>結果不確=
定時，可考慮做靜脈攝影、CT、MRI </span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0=
pt'>準確性</span></li>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>近端 DVT</span><span style=3D'font-family:微=
軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style=3D'font-family:=
微軟正黑體;
        font-size:11.0pt;color:#C00000'>敏感度與特異度約 95%</span>=
</li>
   </ul>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>遠端 DVT</span><span style=3D'font-family:微=
軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style=3D'font-weight:=
bold;
        font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>約 65%=
</span></li>
   </ul>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>床邊超音=
波（POCUS）對近端 DVT
        準確性與正式的超音波相當，但有可能漏診遠端 DVT=
</span></li>
   </ul>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>Doppler
        壓迫性超音波（Compression ultrasound）是診斷 DVT 最準=
的工具</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-US><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0=
pt'>DVT 潛在病因的篩檢</span></li>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>懷疑血栓體質（Thrombophilia）</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>&lt; 45歲發病</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>血栓部位不尋常</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>有家族史、復發或多發性血栓</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>習慣性流產</span></li>
    </ul>
   </ul>
   <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>懷疑惡性腫瘤引起</span><span style=3D'f=
ont-family:微軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style=3D'font-family:=
微軟正黑體;
        font-size:11.0pt;color:#C00000'>DVT 原因不明或復發性 VTE，=
特別是 &gt;50 歲的患者</span></li>
   </ul>
  </ul>
 </ul>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#24=
4061'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16.=
0pt'>處置/治療</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#3=
66092'
       lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:14=
.0pt'>抗凝血治療</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>起始治療</span><span style=3D'font-family:=
軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style=3D'font-family:=
微軟正黑體;
        font-size:11.0pt;color:#C00000'>5–10 天</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:#C00000'>Low-molecular weight heparin, LMWH（enoxapa=
rin）</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>：</span><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt;color:#F79646'>懷孕、肝病、癌症首選</span></li>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:#C00000'>Fondaparinux</span><span style=3D'font-famil=
y:
         微軟正黑體;font-size:11.0pt;color:black'>：</span><span styl=
e=3D'font-weight:
         bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>=
 HIT 病史</span></li>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:#C00000'>Unfractionated heparin（UFH）</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>：</span><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt;color:#F79646'>腎衰竭、肥胖、出血風險高</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt;
          color:#C00000'>使用 UFH 可能引起 Heparin-Induced
          Thrombocytopenia（HIT），應定期監測</span></li>
     </ul>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>Dabigatran/Edoxaban</span><span style=3D'font-=
family:
         微軟正黑體;font-size:11.0pt;color:black'>：需 </span><span =
style=3D'font-family:
         微軟正黑體;font-size:11.0pt;color:#C00000'>parenteral lead-in=
</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>Apixaban/Rivaroxaban</span><span style=3D'font=
-family:
         微軟正黑體;font-size:11.0pt;color:black'>：</span><span styl=
e=3D'font-weight:
         bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>=
直接口服</span></li>
    </ul>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>長期治療</span><span style=3D'font-family:=
軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style=3D'font-family:=
微軟正黑體;
        font-size:11.0pt;color:#C00000'>3–6 個月</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt'>適應症</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt;
          color:#C00000'>有嚴重症狀和/或血栓延伸風險的孤立=
遠端 DVT</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt'>有下列情況且出血風險高：</span></li>
      <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-to=
p:0in;
       margin-bottom:0in'>
       <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#C00000' lang=3Den-US><span style=3D'font-family:微軟正=
黑體;font-size:
           11.0pt'>近端 DVT</span></li>
       <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#C00000' lang=3Den-US><span style=3D'font-family:微軟正=
黑體;font-size:
           11.0pt'>復發性 DVT</span></li>
      </ul>
      <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-to=
p:0in;
       margin-bottom:0in'>
       <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;
           color:black' lang=3Den-US><span style=3D'font-family:微軟正=
體;font-size:
           11.0pt;color:#C00000'>暫時性誘發因子（如手術）引起=
的 DVT</span></li>
      </ul>
     </ul>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>DOACs</span><span style=3D'font-family:微軟=
黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-family=
:微軟正黑體;
         font-size:11.0pt;color:#C00000'>首選</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt'>Factor Xa inhibitor</span><span style=3D'font-f=
amily:
          微軟正黑體;font-size:11.0pt'>：Apixaban、Rivaroxaban、Edo=
xaban</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt'>Thrombin inhibitor</span><span style=3D'font-fa=
mily:
          微軟正黑體;font-size:11.0pt'>：Dabigatran</span></li>
      <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-to=
p:0in;
       margin-bottom:0in'>
       <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
           lang=3Den-US><span style=3D'font-family:微軟正黑體;font-siz=
e:11.0pt'>Dabigatran/Edoxaban：需
           parenteral lead-in </span></li>
       <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
           lang=3Den-US><span style=3D'font-family:微軟正黑體;font-siz=
e:11.0pt'>Apixaban/Rivaroxaban：可直接口服使用</span></li>
      </ul>
     </ul>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:#C00000'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt;color:black'>優點</span><span style=3D'font-fa=
mily:微軟正黑體;
          font-size:11.0pt;color:black'>：</span><span style=3D'font-famil=
y:微軟正黑體;
          font-size:11.0pt;color:#C00000'>不需常規監測、重大出血=
風險較低</span></li>
     </ul>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt;color:black'>禁忌症</span><span style=3D'font=
-family:
          微軟正黑體;font-size:11.0pt;color:black'>：</span><span sty=
le=3D'font-family:
          微軟正黑體;font-size:11.0pt;color:#C00000'>懷孕</span></li>
     </ul>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>Warfarin</span><span style=3D'font-family:微=
正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-weight=
:bold;
         font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>次選=
</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt;color:#C00000'>需橋接治療</span></li>
      <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-to=
p:0in;
       margin-bottom:0in'>
       <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;
           color:black' lang=3Den-US><span style=3D'font-weight:bold;font-f=
amily:
           微軟正黑體;font-size:11.0pt;color:#F79646'>與 LMWH 或 UFH=
 合併使用至少 5 天，期間 INR
           維持 2–3 至少 48小時</span></li>
      </ul>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt;color:black'>禁忌症</span><span style=3D'font=
-family:
          微軟正黑體;font-size:11.0pt;color:black'>：</span><span sty=
le=3D'font-family:
          微軟正黑體;font-size:11.0pt;color:#C00000'>懷孕</span></li>
     </ul>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>LMWH（enoxaparin）</span><span style=3D'font=
-family:
         微軟正黑體;font-size:11.0pt;color:black'>：</span><span styl=
e=3D'font-family:
         微軟正黑體;font-size:11.0pt;color:#C00000'>懷孕首選</span=
></li>
    </ul>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>延長治療</span><span style=3D'font-family:=
軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style=3D'font-family:=
微軟正黑體;
        font-size:11.0pt;color:#C00000'>無期限</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>適應症</span><span style=3D'font-family:微=
軟正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-family=
:微軟正黑體;
         font-size:11.0pt;color:#C00000'>病人出血風險低或中等</sp=
an></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt;color:#F79646'>沒有誘發因子</span><span st=
yle=3D'font-family:
          微軟正黑體;font-size:11.0pt;color:black'>的近端及復發=
DVT</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt;
          color:black'>因慢性誘發因子（如</span><span style=3D'fon=
t-weight:bold;
          font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>癌=
、易產生血栓的體質</span><span
          style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black=
'>）造成的 DVT</span></li>
     </ul>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt'>選項</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:black'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt;color:black'>首次 DVT 發作</span><span style=
=3D'font-family:
          微軟正黑體;font-size:11.0pt;color:black'>：</span><span sty=
le=3D'font-weight:
          bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>=
持續使用原先長期抗凝劑</span><span
          style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black=
'>（warfarin 或
          DOACs）</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt'>抗凝血治療中仍復發</span></li>
      <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-to=
p:0in;
       margin-bottom:0in'>
       <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;
           color:black' lang=3Den-US><span style=3D'font-weight:bold;font-f=
amily:
           微軟正黑體;font-size:11.0pt;color:black'>若本來使用DOA=
Cs</span><span
           style=3D'font-family:微軟正黑體;font-size:11.0pt;color:blac=
k'>，可</span><span
           style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00=
000'>改為 LMWH </span></li>
       <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;
           color:black' lang=3Den-US><span style=3D'font-weight:bold;font-f=
amily:
           微軟正黑體;font-size:11.0pt;color:black'>若本來已使用=
 LMWH</span><span
           style=3D'font-family:微軟正黑體;font-size:11.0pt;color:blac=
k'>：</span><span
           style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00=
000'>劑量增加 25–33%</span></li>
      </ul>
     </ul>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt'>監測</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt'>：每年=
新評估出血風險</span></li>
    </ul>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>癌症病人的抗凝血治療</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>時間</span><span style=3D'font-family:微軟=
正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-family=
:微軟正黑體;
         font-size:11.0pt;color:#C00000'>至少 6 個月</span></li>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>首選</span><span style=3D'font-family:微軟=
正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-family=
:微軟正黑體;
         font-size:11.0pt;color:#C00000'>LMWH、edoxaban、rivaroxaban、ap=
ixaban</span></li>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>替代</span><span style=3D'font-family:微軟=
正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-weight=
:bold;
         font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>warfar=
in</span></li>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt'>若接受化療或有轉移</span><span style=3D'font-fami=
ly:微軟正黑體;font-size:11.0pt'>：延長治療</span></li>
    </ul>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#3=
66092'
       lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:14=
.0pt'>導管溶栓術（Catheter-directed
       thrombolysis, CDT）</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>適應症</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>危及肢體（limb-threatening）缺血</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>急性（&lt;14天）髂股靜脈
         DVT</span></li>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt'>出血風險低</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt'
         lang=3Den-US>預期壽命 </span><span style=3D'font-weight:bold;f=
ont-family:"Microsoft JhengHei Light";
         font-size:11.0pt' lang=3D"x-IV_mathan">≥</span><span style=3D'fo=
nt-weight:
         bold;font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>1 =
年</span></li>
    </ul>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>藥物</span><span style=3D'font-family:微軟=
黑體;font-size:
        11.0pt;color:black'>：</span><span style=3D'font-weight:bold;font-=
family:
        微軟正黑體;font-size:11.0pt;color:#F79646'>streptokinase、uro=
kinase、rtPA</span></li>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>絕對禁忌症</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>過去 3
         個月內曾有缺血性或出血性中風</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>過去 3
         個月內有頭部創傷</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>過去 6
         個月內接受神經外科手術</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>有已知的顱內腫瘤</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>6
         週內有內出血、活動性出血，或已知的出血性疾病=
</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>3
         週內曾接受心肺復甦術</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>疑似主動脈剝離</span></li>
    </ul>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#3=
66092'
       lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:14=
.0pt'>手術性靜脈血栓切除術（Operative
       Venous Thrombectomy）</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>適應症</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
black'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt;color:#C00000'>抗凝治療下病情惡化</span></li>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>進展到青腫性靜脈炎（phlegmasia
         cerulea dolens）</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>進展至靜脈性壞疽</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>病人有CDT的絕對禁忌症</span></li>
    </ul>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>手術步驟</span></li>
    <ol type=3Di style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in;font-family:微軟正黑體;font-size:11.0pt;font-we=
ight:normal;
     font-style:normal'>
     <li value=3D1 style=3D'margin-top:0;margin-bottom:0;vertical-align:mid=
dle'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt;font-weight:
         normal;font-style:normal;font-family:微軟正黑體;font-size:11.=
0pt'>若有
         phlegmasia cerulea dolens，先對小腿進行</span><span style=
=3D'font-family:微軟正黑體;
         font-size:11.0pt;font-weight:bold;font-style:normal;font-weight:bo=
ld;
         font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>筋膜=
切開術（fasciotomy）</span></li>
    </ol>
    <ol type=3Di style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in;font-family:微軟正黑體;font-size:11.0pt;font-we=
ight:bold;
     font-style:normal'>
     <li value=3D2 style=3D'margin-top:0;margin-bottom:0;vertical-align:mid=
dle;
         font-weight:bold;color:#F79646' lang=3Den-US><span style=3D'font-f=
amily:
         微軟正黑體;font-size:11.0pt;font-weight:bold;font-style:norma=
l;font-weight:
         bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>=
股靜脈進行</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;font-weight:=
normal;
         font-style:normal;font-weight:normal;font-family:微軟正黑體;f=
ont-size:11.0pt;
         color:#C00000'>縱向靜脈切開（venotomy）</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;font-w=
eight:
         bold;color:#F79646' lang=3Den-US><span style=3D'font-weight:normal;
         font-family:微軟正黑體;font-size:11.0pt;color:black'>將</spa=
n><span
         style=3D'font-weight:normal;font-family:微軟正黑體;font-size:=
11.0pt;
         color:#C00000'>靜脈氣球導管</span><span style=3D'font-weight=
:normal;
         font-family:微軟正黑體;font-size:11.0pt;color:black'>（venou=
s balloon
         embolectomy catheter）</span><span style=3D'font-weight:bold;font=
-family:
         微軟正黑體;font-size:11.0pt;color:#F79646'>穿過血栓送入=
下腔靜脈</span><span
         style=3D'font-weight:normal;font-family:微軟正黑體;font-size:=
11.0pt;
         color:black'>，然後</span><span style=3D'font-weight:bold;font-=
family:微軟正黑體;
         font-size:11.0pt;color:#F79646'>多次向後拉回</span><span sty=
le=3D'font-weight:
         normal;font-family:微軟正黑體;font-size:11.0pt;color:black'>=
</span><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt;color:#F79646'>直到無法再抽出血栓為止</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt'>下肢遠端血栓</span><span style=3D'font-fa=
mily:微軟正黑體;
          font-size:11.0pt'>：以</span><span style=3D'font-family:微軟=
黑體;font-size:
          11.0pt;color:#C00000'>彈性繃帶</span><span style=3D'font-fami=
ly:微軟正黑體;
          font-size:11.0pt'>從足部至大腿綁緊纏繞，再由足部=
始進行手動擠壓，移除血栓</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt'>陳舊性股靜脈血栓，且無法移除</spa=
n><span style=3D'font-family:微軟正黑體;
          font-size:11.0pt'>：</span><span style=3D'font-family:微軟正=
體;font-size:
          11.0pt;color:#C00000'>結紮靜脈</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt'>血栓延伸至下腔靜脈</span><span style=
=3D'font-family:微軟正黑體;
          font-size:11.0pt'>：</span><span style=3D'font-family:微軟正=
體;font-size:
          11.0pt;color:#C00000'>經腹膜暴露下腔靜脈（IVC），打=
下腔靜脈</span><span
          style=3D'font-family:微軟正黑體;font-size:11.0pt'>，並以=
和按摩方式取出血栓</span></li>
     </ul>
    </ol>
    <ol type=3Di style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in;font-family:微軟正黑體;font-size:11.0pt;font-we=
ight:normal;
     font-style:normal'>
     <li value=3D4 style=3D'margin-top:0;margin-bottom:0;vertical-align:mid=
dle'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt;font-weight:
         normal;font-style:normal;font-family:微軟正黑體;font-size:11.=
0pt'>術中進行</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;font-weight:=
normal;
         font-style:normal;font-family:微軟正黑體;font-size:11.0pt;col=
or:#C00000'>靜脈攝影（completion
         venogram）</span><span style=3D'font-family:微軟正黑體;font-=
size:11.0pt;
         font-weight:bold;font-style:normal;font-weight:bold;font-family:=
軟正黑體;
         font-size:11.0pt;color:#F79646'>評估是否有殘餘血栓或狹=
</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;font-weight:=
normal;
         font-style:normal;font-family:微軟正黑體;font-size:11.0pt'>=
</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;font-weight:=
normal;
         font-style:normal;font-family:微軟正黑體;font-size:11.0pt;col=
or:#C00000'>若髂靜脈有狹窄，可在術中施行血管成形術（ang=
ioplasty）及置放支架</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>建立動靜脈瘻管（arteriovenous
         fistula）</span><span style=3D'font-family:微軟正黑體;font-s=
ize:11.0pt'>，</span><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11=
.0pt;color:#F79646'>將大隱靜脈（great
         saphenous vein）末端與淺股動脈（superficial femoral arter=
y）作側端吻合（end to side）</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt'>，讓血=
切除後的髂股靜脈維持通暢</span></li>
    </ol>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>術後使用Heparin，其後持續使用
        warfarin 至少 6 個月</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#3=
66092'
       lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:14=
.0pt'>下腔靜脈過濾器（IVC
       filter / Greenfield filter）</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>目的</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>：</span><s=
pan
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>預防肺栓塞</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>，維持下=
腔靜脈（IVC）的通暢性</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt'>適應症</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>在充分抗凝治療下仍反覆發生血栓栓塞</span></li>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=
=3Den-US><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>具有抗凝治療禁忌症</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt'>的深層=
脈血栓（DVT）患者</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt;color:#F79646'>活動性出血 </span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt'>最近接受重大</span><span
          style=3D'font-weight:bold;font-family:微軟正黑體;font-size:1=
1.0pt;
          color:#F79646'>神經外科或腹部手術</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt'>近期有</span><span
          style=3D'font-weight:bold;font-family:微軟正黑體;font-size:1=
1.0pt;
          color:#F79646'>顱內出血或腦外傷</span></li>
     </ul>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:#F79646'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt'>先天或後天嚴重凝血功能異常</span><=
/li>
     </ul>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt;color:#F79646'>主動脈剝離</span><span style=
=3D'font-family:
          微軟正黑體;font-size:11.0pt'>或</span><span style=3D'font-w=
eight:bold;
          font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>重=
胸腹部創傷</span></li>
     </ul>
    </ul>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt;color:#C00000'>慢性肺栓塞</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>及</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>肺高壓</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt'>抗凝治療時發生併發症</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#C00000'
         lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt;color:black'>在抗凝治療期間</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C0000=
0'>持續惡化的髂股靜脈血栓</span></li>
    </ul>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>常規放置仍具爭議性，</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>IVC filter
        並未顯著延長存活率</span><span style=3D'font-family:微軟=
正黑體;font-size:11.0pt;
        color:black'>，雖</span><span style=3D'font-weight:bold;font-fami=
ly:微軟正黑體;
        font-size:11.0pt;color:#F79646'>可降低肺栓塞發生率</span><=
span style=3D'font-family:
        微軟正黑體;font-size:11.0pt;color:black'>，但同時</span><s=
pan style=3D'font-weight:
        bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>=
增加 DVT 再發率</span></li>
   </ul>
  </ul>
 </ul>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#24=
4061'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16.=
0pt'>併發症</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#F=
79646'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>肺栓塞（Pulmonary embolism）</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>最常起源於</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>下肢近端深部靜脈</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
，如</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt;color:#F79646'>髂靜脈、股靜脈或膕靜脈</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#F=
79646'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>血栓後症候群（Postthrombotic syndrome，P=
TS）</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>又稱慢性靜脈功能不全（chronic
        venous insufficiency）</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:#C00000'>20%
        至 50%</span><span style=3D'font-family:微軟正黑體;font-size:=
11.0pt;color:black'>
        的病人在曾經發生過 DVT 後會出現</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>風險因子</span></li>
     <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
      margin-bottom:0in'>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:#F79646'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt'>急性 DVT 發作後數月內仍持續出現腿=
部症狀</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:#F79646'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt;
          color:black'>解剖學上</span><span style=3D'font-weight:bold;f=
ont-family:
          微軟正黑體;font-size:11.0pt;color:#F79646'>範圍廣泛、=
及髂股靜脈系統</span><span
          style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black=
'>的 DVT</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:#F79646'
          lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟=
黑體;
          font-size:11.0pt'>同側反覆性 DVT</span></li>
      <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color=
:#F79646'
          lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size=
:11.0pt;
          color:black'>抗凝治療劑量未達治療濃度</span></li>
     </ul>
    </ul>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>臨床表現</span><span style=3D'font-family:=
軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style=3D'font-family:=
微軟正黑體;
        font-size:11.0pt;color:#C00000'>慢性水腫、疼痛、靜脈性=
歇性跛行</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
，甚至可能出現</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>靜脈潰瘍</span></li>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:#C00000'>支持性治療</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
為主：</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.=
0pt;color:black'>壓迫治療（compression
        therapy）</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#F=
79646'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:#131314'>敗血性</span><span style=3D'font-weight:bol=
d;
       font-family:微軟正黑體;font-size:11.0pt;color:black'>血栓性=
脈炎（Septic
       thrombophlebitis）</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>使用不潔針具進行靜脈注射毒品</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#F=
79646'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>靜脈性壞疽（Venous gangrene）</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt'>罕見</span></li>
   </ul>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:1=
1.0pt;color:black'>常見於有</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>後天高凝血狀態</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
的病人（如</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>惡性腫瘤、肝素引起的血小板減少症、抗磷脂症候群</sp=
an><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'>=
），</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt;color:#C00000=
'>且正在使用Warfarin治療</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#F=
79646'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>治療相關併發症</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>IVC filter</span><span style=3D'font-family:微=
軟正黑體;
        font-size:11.0pt;color:black'>：移位、濾網破裂、移位或=
透 IVC、插入部位血栓形成或出血、下腔靜脈閉塞</span></=
li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
F79646'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>血栓溶解</span><span style=3D'font-family:=
軟正黑體;
        font-size:11.0pt;color:black'>：出血</span></li>
    <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:=
0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>Heparin</span><span style=3D'font-family:微=
正黑體;
         font-size:11.0pt;color:black'>：</span><span style=3D'font-family=
:微軟正黑體;
         font-size:11.0pt;color:#C00000'>HIT（1-5%）</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt;color:black'=
>、骨質疏鬆</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:=
#F79646'
         lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
黑體;font-size:
         11.0pt;color:black'>Warfarin</span><span style=3D'font-family:微=
正黑體;
         font-size:11.0pt;color:black'>：皮膚壞死</span></li>
    </ul>
   </ul>
  </ul>
 </ul>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#24=
4061'
      lang=3Den-US><span style=3D'font-family:微軟正黑體;font-size:16.=
0pt'>預後</span></li>
  <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0i=
n;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C=
00000'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>DVT 的 1 個月內死亡率</span><span style=
=3D'font-family:微軟正黑體;
       font-size:11.0pt;color:black'>：約 </span><span style=3D'font-fami=
ly:微軟正黑體;
       font-size:11.0pt;color:#C00000'>6%</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C=
00000'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>接受抗凝治療後 6 個月內，VTE 復發=
</span><span style=3D'font-family:
       微軟正黑體;font-size:11.0pt;color:black'>： </span><span style=
=3D'font-family:
       微軟正黑體;font-size:11.0pt;color:#C00000'>6–7%</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>未經治療的下肢 DVT 復發率</span><span=
 style=3D'font-family:
        微軟正黑體;font-size:11.0pt;color:black'>：</span><span style=
=3D'font-family:
        微軟正黑體;font-size:11.0pt;color:#C00000'>30%</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C=
00000'
       lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
       11.0pt;color:black'>首次 DVT 後 28 天的死亡率</span><span st=
yle=3D'font-family:
       微軟正黑體;font-size:11.0pt;color:black'>：</span><span style=
=3D'font-family:
       微軟正黑體;font-size:11.0pt;color:#C00000'>9.4%</span></li>
   <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0=
in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#=
C00000'
        lang=3Den-US><span style=3D'font-weight:bold;font-family:微軟正=
體;font-size:
        11.0pt;color:black'>若因DVT造成肺栓塞</span><span style=3D'f=
ont-family:微軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style=3D'font-family:=
微軟正黑體;
        font-size:11.0pt;color:#C00000'>15.1%</span></li>
   </ul>
  </ul>
 </ul>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C0=
0000'
      lang=3Den-GB><span style=3D'font-weight:bold;font-family:Calibri;font=
-size:
      16.0pt;color:black'>Reference</span></li>
  <ol type=3D1 style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;mar=
gin-bottom:
   0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:n=
ormal'>
   <li value=3D1 style=3D'margin-top:0;margin-bottom:0;vertical-align:middl=
e'><span
       style=3D'font-family:Calibri;font-size:11.0pt;font-weight:normal;
       font-style:normal;font-family:Calibri;font-size:11.0pt'>Sabiston
       Textbook of Surgery 21st Edition </span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:Calibri;font-size:11.0pt'>Schwartz's Principles=
 of
       Surgery 11th Edition</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3D=
en-GB><span
       style=3D'font-family:Calibri;font-size:11.0pt'>Peripheral arterial
       disease, AMBOSS</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:Calibri;font-size:11.0pt'>Bikdeli B, Chatterjee=
 S,
       Desai NR, Kirtane AJ, Desai MM, Bracken MB, Spencer FA, Monreal M,
       Goldhaber SZ, Krumholz HM. Inferior Vena Cava Filters to Prevent
       Pulmonary Embolism: Systematic Review and&nbsp;Meta-Analysis. J Am C=
oll
       Cardiol. 2017 Sep 26;70(13):1587-1597. doi: 10.1016/j.jacc.2017.07.7=
75.
       PMID: 28935036; PMCID: PMC8412839.</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:Calibri;font-size:11.0pt'>Key NS, Khorana AA, K=
uderer
       NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR,
       Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA,
       Lyman GH, Falanga A. Venous Thromboembolism Prophylaxis and Treatmen=
t in
       Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin
       Oncol. 2020 Feb 10;38(5):496-520. doi: 10.1200/JCO.19.01461. Epub 20=
19
       Aug 5. PMID: 31381464.</span></li>
  </ol>
 </ul>
</ul>

</div>

</div>

</div>

<div>

<p style=3D'margin:0in'>&nbsp;</p>

<p style=3D'text-align:left;margin:0in;font-family:Arial;font-size:9pt;
color:#969696;direction:ltr'>使用 OneNote 建立。</p>

</div>

</body>

</html>
